Lv5
855 积分 2021-02-26 加入
Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study
13天前
已完结
二甲双胍临床应用专家共识（2023年版）
19天前
已完结
中国2型糖尿病防治指南（2020年版）
26天前
已完结
中国糖尿病患者低血糖管理的专家共识
26天前
已完结
LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels
1个月前
已完结
A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects
1个月前
已完结
Guideline for the Management of Fever and Neutropenia in Children With Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
2个月前
已完结
Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials
2个月前
已完结
Population Pharmacokinetics and Exposure-Response Analysis of nab-Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors
2个月前
已完结
larification on Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetic Studies
2个月前
已完结
皖公网安备34019202002308
